Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer

Vascular-targeted photodynamic therapy (VTP) induces rapid destruction of targeted tissues and is a promising therapy for prostate cancer. However, the resulting immune response, which may play an important role in either potentiating or blunting the effects of VTP, is still incompletely understood....

Full description

Bibliographic Details

Published in:	Oncoimmunology Vol. 8; no. 6; p. e1581528
Main Authors:	Lebdai, Souhil, Gigoux, Mathieu, Alvim, Ricardo, Somma, Alexander, Nagar, Karan, Azzouzi, Abdel Rahmene, Cussenot, Olivier, Merghoub, Taha, Wolchok, Jedd D., Scherz, Avigdor, Kim, Kwanghee, Coleman, Jonathan
Format:	Journal Article
Language:	English
Published:	United States Taylor & Francis 03.06.2019 Taylor & Francis Group
Subjects:	CSF-1R immunotherapy MDSCs myeloid cells Original Research Prostate cancer vascular-targeted photodynamic therapy WST11 MDSCs myeloid cells vascular-targeted photodynamic therapy immunotherapy WST11 Prostate cancer CSF-1R
ISSN:	2162-402X, 2162-4011, 2162-402X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!